Key Points {#d30e287}
==========

When dietary supplement use was compiled by sport, elite versus non-elite athletic status, and supplement type there was high variability in use prevalence among studies.Elite athletes appeared to use dietary supplements much more than their non-elite counterparts.For most dietary supplements, use prevalence appeared similar for men and women. Exceptions were that a larger proportion of women used iron and a larger proportion of men used vitamin E, protein, and creatine.

Introduction {#Sec1}
============

A dietary supplement is a commercially available product that is consumed as an addition to the usual diet and includes vitamins, minerals, herbs (botanicals), amino acids, and a variety of other products \[[@CR1]\]. Marketing claims for some dietary substances include improvements in overall health status, enhancement of cognitive or physical performance, increase in energy, loss of excess weight, attenuation of pain, and other favorable effects. The Dietary Supplement Health and Education Act (DSHEA) of 1994 \[[@CR2]\] established the regulatory framework for dietary supplements in the US. Since this act became law, US sales of dietary supplements has increased from \$US4 billion in 1994 to \$US33 billion in 2012 \[[@CR3], [@CR4]\], an eightfold increase over 18 years. Global sales of supplements were \$US96 billion in 2012 and estimated at \$US104 billion in 2013 \[[@CR5]\].

Patterns of dietary supplement use may differ in distinctive subpopulations. Athletes in different sports may use different dietary supplements depending on the nature of the physical activities they perform and the desired outcomes from the dietary supplements. Athletes often perform intense and prolonged physical activity and often report that their primary reason for using dietary supplements is to enhance performance or recover from exercise \[[@CR6]--[@CR14]\], although improving/maintaining health can also be an important rationale \[[@CR15]--[@CR19]\]. In contrast, the general population appears to consume dietary supplements primarily for health-related reasons, with only minor interest in performance enhancement \[[@CR20], [@CR21]\]. Competitive athletes also need to be concerned with excessive use and possible adverse interactions due to polypharmacy \[[@CR22], [@CR23]\], and inadvertent doping due to the inadequate quality control of some dietary supplements \[[@CR24], [@CR25]\].

This paper presents a systematic literature review describing the prevalence of dietary supplement use in athletes. Where possible, meta-analyses were performed on dietary supplements by sport and sex, by elite versus non-elite athletic status, and by specific dietary supplements for all athletic groups combined. An older review on the prevalence of vitamin and mineral supplementation by athletes is also available \[[@CR26]\].

Methods {#Sec2}
=======

This investigation generally followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines \[[@CR27]\].

Information Sources and Search {#Sec3}
------------------------------

Literature searches were conducted in PubMed, Ovid MEDLINE (including OLDMEDLINE), OVID Healthstar, and Cumulative Index to Nursing and Allied Health Literature (CINAHL). No limitations were placed on the dates of the searches, and the final search was completed in August 2014. After reviewing PubMed medical subject headings for 'dietary supplements' and 'athletes', keywords selected for the search included athlete, sport, football, wrestling, soccer, ballet, dancing, running, gymnastics, swimming, basketball, hockey, tennis, softball, baseball, triathlete, triathlon, body building, weight lifting, volleyball, track, and crew. These keywords were combined with nutrition, dietary supplement, supplement, vitamin, mineral, amino acid, protein, herb, herbal, sport drink, sport bar, nutriceutical, neutraceuticals, food supplements, and food supplementation. To find additional studies, the reference lists of the articles obtained were searched, as was the literature database of an investigator with extensive experience with dietary supplement research.

Eligibility Criteria {#Sec4}
--------------------

Articles were selected for the review if they were (1) written in English, (2) involved athletes, and (3) provided a quantitative assessment of the proportion of athletes using dietary supplements of any type, as defined by the DSHEA of 1994 \[[@CR2]\]. Titles were first examined and abstracts were reviewed if the article appeared to involve athletes and either nutrition or dietary supplements. The full text of the article was retrieved if there was a possibility that dietary supplements were included within the investigation. Quantitative prevalence data could be contained within the text of the article, in tabular form, or presented in graphs. Data presented in graphic form were estimated. If the authors did not specifically reference dietary supplement prevalence, but data were available in the article to calculate it, then the article and the data were included in the review.

Not included in the review were studies that (1) examined athletic-related occupations (coaches, athletic trainers, physicians) or former athletes; (2) asked athletes about dietary supplements they would like to use (as opposed to actual use); (3) asked athletes about dietary supplement use they had observed; (4) mixed athletes with non-athletes, unless the athlete data were reported separately or could be calculated from the data provided; and (5) examined dietary supplement use during competitive events (because of the short timeframe and special, atypical circumstances). A number of studies that were identified did consider intake of dietary supplements in calculating nutritional intake of various athletic groups but did not specifically report the dietary supplement prevalence and so could not be used in this review. Abstracts, case studies, and case series were also not included. Stand-alone abstracts (without full-text articles) were excluded because they were difficult to locate, were generally not included in reference databases, and in many cases were not peer reviewed. Case studies and case series involved few individuals and were often published because they were atypical.

Summary Measure {#Sec5}
---------------

The summary statistic was the percent of athletes using a specific dietary supplement. Data extracted from each study were (1) the number of athletes using a particular dietary supplement and (2) the number of athletes in the entire sample. Dividing the former by the latter and multiplying by 100 % produced the use prevalence as a percent. Data from a number of studies required recalculation because authors expressed data as a percent of dietary supplement users rather than as a percent of the total sample.

Considerations in Data Collection and Compilation {#Sec6}
-------------------------------------------------

A "unique study" was defined as a single data collection period. Multiple publications could be produced from a single unique study. When there were multiple publications from a unique study, all dietary supplement prevalence reported in any of the publications were included in the data extraction process; however, the publication was included only once in the analyses so as not to bias prevalence estimates to studies with more publications.

To be included in the review, the dietary supplement examined in the publication had to be specifically identified. That is, dietary supplements grouped into categories like 'antioxidant', 'pro-performance', 'herbal supplement', 'ergogenics', 'thermogenics', 'bodybuilding', and the like were not included in the data extraction process. Exceptions were the general category of vitamins and minerals, which were included since so many studies reported these. Sport drinks, sports bars, and energy drinks were also included in the review for the same reason, although these substances are classified as 'nutritional supplements' since they contain nutritional labeling as specified by the DSHEA. Brand names that contained multiple supplements were not included unless the brand name could be identified as having a single major identifiable dietary supplement.

To summarize the raw data, two major tables were constructed, one describing the methodology used by each study \[see Table S1 in the Electronic Supplementary Material (ESM)\], the other containing the prevalences of the most frequently reported dietary supplements (see Table S2 in the ESM).

Methodological Quality Ratings {#Sec7}
------------------------------

Methodology quality of the investigations was assessed using the technique of Loney et al. \[[@CR28]\], which was developed specifically for rating prevalence investigations. Studies were graded on an 8-point scale that included evaluations for sampling methods, sampling frame, sample size, measurement tools, bias, response rate, statistical presentation, and description of the participant sample. The eight items were rated as either 'yes' (1 point) or 'no' (no point), based on specific criteria. Thus, the maximum possible score was 8. Three authors independently rated each of the selected articles. Following the independent evaluations, the reviewers met to examine the scores and reconcile major differences. The average score of the reviewers served as the methodological quality score. Scores were converted to a percent of the total available points by dividing the average score for each study by 8 and multiplying by 100 %.

Meta-Analyses {#Sec8}
-------------

We used the Comprehensive Meta-Analysis Statistical Package, Version 3.2 (Biostat, Englewood, NJ, USA) to perform meta-analyses on (1) dietary supplement prevalence by sport and sex; (2) dietary supplement prevalence by elite versus non-elite athletic status; and (3) prevalence by specific dietary supplements for all athletic groups combined. These analyses required at least two studies and only studies that queried athletes about 'current', 'usual', or 'regular' use of dietary supplements were considered so that the reporting timeframe was similar. Studies asking about the use of dietary supplements at other times (e.g., last 2 months, last 6 months, etc.) were not included in the meta-analyses. For the sport-specific meta-analyses, the sport had to be explicit (e.g., football, basketball, tennis). If sports were grouped into broad categories (e.g., 'combat sports', 'racquet sports', 'speed sports', 'power sports', 'endurance sports', 'ball sports'), they were not included. Elite athletes were defined as those competing professionally, at national or international level. Athletes competing at high schools, colleges, or universities were not considered elite. Only studies that involved adults and provided separate prevalence data for men and women were included in the elite versus non-elite meta-analyses. If sample sizes were not provided for a particular group or subgroup, the study could not be included because sample sizes are required for meta-analysis.

For all meta-analyses, we used a random model that considered users and non-users of dietary supplements to produce a summary prevalence estimate (SPE) and a summary 95 % confidence interval (S95 % CI) that represented the pooled data of all the individual investigations. Homogeneity of the pooled prevalence estimates was assessed using the *Q*- and the *I*^2^-statistics \[[@CR29]\]. *I*^2^ indicated the percent of heterogeneity among studies, with smaller values denoting more homogeneity and larger values less homogeneity. In calculating *I*^2^, negative values were set to zero, which indicated very little heterogeneity \[[@CR30]\]. Where there were four or more studies, publication bias was assessed by examining the symmetry of study data in funnel plots (1/standard error of prevalences vs. logit of the prevalences) and further appraising the information with the trim and fill evaluation. The trim and fill evaluation imputes the number of 'missing' studies in the funnel plot and re-computes an adjusted SPE and S95 % CI with the 'missing' studies included \[[@CR31]\]. Where there were fewer than four studies, symmetry of studies about the funnel plot could not be interpreted.

Results {#Sec9}
=======

Figure [1](#Fig1){ref-type="fig"} shows the number of publications included and excluded at each stage of the literature search. The initial search identified 16,694 citations, 5926 of which were duplicate publications (from different databases) that were removed. Based on a review of titles and abstracts, 311 full articles were obtained for review, and subsequently 136 were removed for not having information on prevalence or meeting the exclusion criteria. A total of 175 studies were further reviewed, but 16 of these did not contain useful data because of the manner in which the dietary supplements were categorized ('antioxidant', 'pro-performance', 'herbal supplement', etc.). In total, 159 unique studies (and 165 published papers) finally met the inclusion criteria. Two unique studies produced two reports each \[[@CR32]--[@CR35]\], one resulted in three publications \[[@CR36]--[@CR38]\], and one resulted in four articles \[[@CR12], [@CR39]--[@CR41]\].Fig. 1Publications included and excluded at each stage of literature review

Study Methodologies {#Sec10}
-------------------

Table S1 in the ESM shows the participants and methods in the 159 unique investigations. In terms of specific sports, there were 14 studies of football players \[[@CR7], [@CR8], [@CR42]--[@CR53]\]; 12 of swimmers \[[@CR7], [@CR44], [@CR45], [@CR48], [@CR54]--[@CR61]\] and soccer players \[[@CR7], [@CR44], [@CR45], [@CR48], [@CR52], [@CR62]--[@CR68]\]; ten of body builders \[[@CR6], [@CR69]--[@CR77]\] and basketball players \[[@CR7], [@CR42]--[@CR46], [@CR52], [@CR78]--[@CR80]\]; nine of volleyball players \[[@CR7], [@CR43]--[@CR47], [@CR49], [@CR52], [@CR81]\]; eight of wrestlers \[[@CR7], [@CR42]--[@CR45], [@CR47], [@CR48], [@CR82]\] and tennis players \[[@CR7], [@CR43]--[@CR48], [@CR52]\]; seven of ballet dancers \[[@CR83]--[@CR89]\] and gymnasts \[[@CR7], [@CR44], [@CR45], [@CR90]--[@CR93]\]; six with marathoners \[[@CR36], [@CR63], [@CR94]--[@CR97]\], baseball players \[[@CR7], [@CR43], [@CR45], [@CR46], [@CR48], [@CR52]\], triathletes \[[@CR63], [@CR98]--[@CR102]\], and golfers \[[@CR7], [@CR44]--[@CR47], [@CR52]\]; five with dancers \[[@CR47], [@CR89], [@CR103]--[@CR105]\]; four with ultra-marathoners \[[@CR106]--[@CR109]\]; three with runners \[[@CR110]--[@CR112]\], figure skaters \[[@CR15], [@CR113], [@CR114]\], alpine skiers \[[@CR44], [@CR48], [@CR115]\], cheerleaders \[[@CR7], [@CR45], [@CR48]\], cross-country runners \[[@CR7], [@CR44], [@CR52]\], lacrosse players \[[@CR44], [@CR45], [@CR48]\], softball players \[[@CR7], [@CR43], [@CR52]\], and ice hockey players \[[@CR44], [@CR116], [@CR117]\]; two with field hockey players \[[@CR45], [@CR48]\]; and one each with aerobic dancers \[[@CR118]\], cyclists \[[@CR119]\], divers \[[@CR45]\], fencers \[[@CR45]\], Nordic skiers \[[@CR115]\], rugby players \[[@CR120]\], sailors \[[@CR121]\], speed skaters \[[@CR122]\], synchronized swimmers \[[@CR89]\], surfers \[[@CR123]\], table tennis players \[[@CR124]\], and weight lifters \[[@CR63]\]. Eight studies involved athletes in 'track and field' sports without defining the specific sport \[[@CR7], [@CR16], [@CR43], [@CR44], [@CR46], [@CR104], [@CR125], [@CR126]\]. Other studies looked at groups of sports with elite athletes \[[@CR9], [@CR13], [@CR14], [@CR18], [@CR19], [@CR34], [@CR35], [@CR127]--[@CR138]\] (including Olympic athletes \[[@CR32], [@CR139]--[@CR145]\]), university or college athletes \[[@CR11], [@CR146]--[@CR156]\], high school athletes \[[@CR157]--[@CR162]\], fitness/health/wellness club or gym users \[[@CR10], [@CR17], [@CR95], [@CR163]--[@CR169]\], and other groups of athletes \[[@CR12], [@CR23], [@CR79], [@CR170]--[@CR177]\].

The data in Table S1 in the ESM indicate that 63 of 159 unique studies (40 %) used questionnaires to obtain dietary supplement information from participants, and these were either focused on general or more specific (e.g., creatine or protein) dietary supplement. A total of 63 studies (40 %) centered on topics other than dietary supplements but included some items on general or specific dietary supplement use. Some studies used dietary records, asking athletes to record what they consumed in periods of 1 day (*n* = 1), 3 days (*n* = 26), 4 days (*n* = 2), 7 days (*n* = 10), or 14 days (*n* = 1), with some studies collecting data over several periods (*n* = 6). A few investigations used dietary recall (*n* = 7) and/or food frequency questionnaires (*n* = 4). Some studies interviewed athletes (*n* = 7) or used interviews in combination with other methods (*n* = 3). In a few cases (*n* = 3), the methods for collecting the study data were not stated.

The data in Table S1 of the ESM indicate that the athletes' reporting timeframe differed among studies. There were 108 studies (68 %) that involved current, regular, or usual use of dietary supplements. Some studies focused on dietary supplement use in specific periods of time including the last 3 days (*n* = 1), last month (*n* = 5), last 2 months (*n* = 1), last 3 months (*n* = 3), last 6 months (*n* = 6), last 12 months (*n* = 5), in the bulking phase of body building (*n* = 1), for \>6 months in the previous 3 years (*n* = 1), or use in athletes' college sports careers (*n* = 1). A number of studies asked about dietary supplement use at any time, currently or in the past (*n* = 14). In some studies, the reporting timeframe was not clear (*n* = 13).

Table S1 in the ESM shows that the proportion of solicited athletes participating in the investigations ranged from 7 to 100 %, with 36 investigations (23 %) achieving ≥66 % participation and 32 studies (20 %) with participation of \<66 %. In 89 studies (56 %), the proportion of the solicited athletes participating in the study was not specified. In two cases (1 %), the nature of the study was such that participation could not be determined (i.e., a case-control study and a study that only reported the proportion of high schools participating).

As shown in Table S1 in the ESM, rating from the methodological quality reviews ranged from 8 to 83 % of available points, with an average ± standard deviation rating of 43 ± 16 %. Only 54 studies (34 %) had scores of ≥50 % and only eight studies (5 %) had scores of ≥70 %. Very few investigations drew true random samples or specified a sampling frame. In some cases, lower methodological quality was associated with the fact that the study was not focused on dietary supplement prevalence. For example, studies on medication use or 'doping' \[[@CR23], [@CR135], [@CR142], [@CR143], [@CR176]\] and studies on the nutritional intake \[[@CR54], [@CR62], [@CR81], [@CR133]\] included information on dietary supplement prevalence, but this was not the main purpose of the investigation. Table [1](#Tab1){ref-type="table"} shows that the methodological quality scores in the studies published in the 1969--1989 period were slightly lower than those published later, but the overall difference between the two publication periods (1969--1989 vs. 1990--2014) was only 6 %.Table 1Methodological quality scores at various publication timesPublication date (year grouping)Studies (*n*)Methodological quality score (mean ± SD)One way analysis of variance *p* value1969--19893837 ± 150.041990--19993245 ± 142000--20095043 ± 132010--20143946 ± 16*SD* standard deviation

Dietary Supplement Use Reported in Individual Investigations {#Sec11}
------------------------------------------------------------

Table S2 in the ESM shows the prevalence of dietary supplement use documented in each study. Information on the prevalence of any dietary supplement use was included in 95 studies (60 %). The use of any vitamins and/or minerals was reported in 67 investigations (42 %), multivitamin/multimineral use in 67 studies (42 %), and specific vitamins and/or minerals in 70 studies (44 %). Amino acid and/or protein supplementation was reported in 82 investigations (52 %), while creatine use was reported in 50 (31 %). There were 27 studies (17 %) that reported on specific herbal supplements. Sports drink use was reported in 33 studies (21 %), sports bar use in 18 studies (11 %), substances containing omega-3 fatty acids in 11 studies (7 %), caffeine use in eight studies (5 %), and energy drink consumption in seven studies (4 %).

Meta-Analyses on Dietary Supplement Prevalence {#Sec12}
----------------------------------------------

Table [2](#Tab2){ref-type="table"} presents the meta-analyses conducted on studies that provided data by sport, sex, and specific dietary supplements and where there were at least two investigations involving specific dietary supplements. Very few investigations provided the necessary data for conducting meta-analyses by these categories. Some studies that would have been appropriate for these analyses did not provide sample sizes by sport \[[@CR43]--[@CR45], [@CR47], [@CR48], [@CR52]\], while other studies that did provide sport and sample size did not separate dietary supplement data by sex \[[@CR56], [@CR58], [@CR60], [@CR61], [@CR96], [@CR106], [@CR109], [@CR112], [@CR113], [@CR118], [@CR121]\]. Where appropriate data were available, many of the SPEs had wide S95 % CIs and low homogeneity. Of the 31 analyses in Table [2](#Tab2){ref-type="table"}, only about half (*n* = 16) had *Q* statistic *p* values \>0.05, and 29 % (*n* = 9) had *I*^2^ values ≤50 %. Despite this, the data suggested that the largest prevalence of dietary supplement use was among male soccer players and body builders, with other groups having lower use prevalences.Table 2Summary data on prevalence of dietary supplement use of athletes by sport and sexSportSubgroupDietary supplementStudiesNationalityIndividual study prevalence (%)Total sample size (*n*)SPE \[% (S95 % CI)\]Homogeneity of SPE*Q* statistic *p* value*I* ^2^ (%)FootballCollege menAny vitaminJonnalagadda 2001 \[[@CR50]\]US23Cole et al. 2005 \[[@CR51]\]US45911 (2--48)0.0671CreatineGreenwood et al. 2000 \[[@CR46]\]US67Jonnalagadda et al. 2001 \[[@CR50]\]US3610752 (23--80)\<0.0188High school malesCreatineSwirzinski 2000 \[[@CR8]\]US29Scofield and Unruh 2006 \[[@CR52]\]US2618229 (23--36)0.770Any vitamin or mineralSobal 1994 \[[@CR44]\]US39Scofield and Unruh 2006 \[[@CR52]\]US179531 (14--56)0.1650SoccerElite menAny DSTscholl et al. 2008 \[[@CR66]\]Mixed43Aljaloud and Ibrahim 2013 \[[@CR68]\]Saudi Arabian93157776 (15--98)\<0.0198Any vitaminBurke et al. 1991 \[[@CR63]\]Australian14Waddington et al. 2005 \[[@CR65]\]UK58223439 (26--55)\<0.0195Tscholl et al. 2008 \[[@CR66]\]Mixed42Amino acidsTscholl et al. 2008 \[[@CR66]\]Mixed8Aljaloud and Ibrahim 2013 \[[@CR68]\]Saudi Arabian2584114 (4--38)\<0.0196CreatineWaddington et al. 2005 \[[@CR65]\]UK37Tscholl et al. 2008 \[[@CR66]\]Mixed8228317 (5--47)\<0.0199Aljaloud and Ibrahim 2013 \[[@CR68]\]Saudi Arabian15Body-buildingMenAny DSFaber 1987 \[[@CR69]\]South African63Linseisen et al. 1993 \[[@CR74]\]German10033782 (57--94)\<0.0190Karimian et al. 2011 \[[@CR77]\]Iranian87Any vitaminBrill and Keane 1994 \[[@CR6]\]US70Karimian et al. 2011 \[[@CR77]\]Iranian5246061 (43--77)\<0.0193Any mineralBrill and Keane 1994 \[[@CR6]\]US49Karimian et al. 2011 \[[@CR77]\]Iranian1546029 (7--68)\<0.0198MVMFaber 1987 \[[@CR69]\]South African37Sandoval et al. 1989 \[[@CR70]\]US2012842 (29--55)0.1842Andersen et al. 1995 \[[@CR76]\]US51Vit AFaber 1987 \[[@CR69]\]South African10Karimian et al. 2011 \[[@CR77]\]Iranian1132411 (8--15)0.680Vit B or B complexFaber 1987 \[[@CR69]\]South African14Andersen et al. 1995 \[[@CR76]\]Iranian2812320 (9--39)0.0476Vit CFaber 1987 \[[@CR69]\]South African31Andersen et al. 1995 \[[@CR76]\]Iranian4612338 (24--55)0.0868ProteinFaber 1987 \[[@CR69]\]South African59Linseisen et al. 1993 \[[@CR74]\]German10034663 (44--79)\<0.0183Brill and Keane 1994 \[[@CR6]\]US61Andersen et al. 1995 \[[@CR76]\]US38Amino acidsBrill and Keane 1994 \[[@CR6]\]US51Andersen et al. 1995 \[[@CR76]\]US5825952 (46--58)0.440WomenAny DSWalberg-Rankin et al. 1993 \[[@CR75]\]US100Karimian et al. 2011 \[[@CR77]\]Iranian1125650 (1--99)\<0.0189Any vitaminBrill and Keane 1994 \[[@CR6]\]US76Karimian et al. 2011 \[[@CR77]\]Iranian434927 (1--96)\<0.0199Any mineralBrill and Keane 1994 \[[@CR6]\]US57Karimian et al. 2011 \[[@CR77]\]Iranian1034928 (3--81)\<0.0199MVMSandoval et al. 1989 \[[@CR70]\]US50Walberg-Rankin et al. 1993 \[[@CR75]\]US331242 (18--70)0.560IronWalberg-Rankin et al. 1993 \[[@CR75]\]US17Karimian et al. 2011 \[[@CR77]\]Iranian52566 (3--15)0.2523CalciumWalberg-Rankin et al. 1993 \[[@CR75]\]US17Karimian et al. 2011 \[[@CR77]\]Iranian72568 (5--12)0.40ProteinWalberg-Rankin et al. 1993 \[[@CR75]\]US50Brill and Keane 1994 \[[@CR6]\]US5410553 (44--63)0.870Amino acidsWalberg-Rankin et al. 1993 \[[@CR75]\]US100Brill and Keane 1994 \[[@CR6]\]Iranian5910573 (27--95)0.1355BalletElite womenAny DSCalabrese et al. 1983 \[[@CR84]\]US40Zenic et al. 2010 \[[@CR89]\]Croatian764659 (23--87)0.0283TriathlonMenAny DSBurke et al. 1991 \[[@CR63]\]Australian44Knez and Peake 2010 \[[@CR101]\]Mixed5825654 (48--60)0.530Dolan et al. 2011 \[[@CR102]\]US55WomenAny DSKnez and Peake 2010 \[[@CR101]\]Mixed69Dolan et al. 2011 \[[@CR102]\]US5320756 (44--67)0.2719DanceWomenAny DSEvers 1987 \[[@CR103]\]US48Sekulic et al. 2008 \[[@CR105]\]Serbian246730 (19--49)0.1155Zenic et al. 2010 \[[@CR89]\]Croatian18Sport drinkSekulic et al. 2008 \[[@CR105]\]Serbian24Zenic et al. 2010 \[[@CR89]\]Croatian184622 (12--36)0.176Ultra- marathonMenMagnesiumPeters and Goetzsche 1997 \[[@CR107]\]Mixed70Knechtle et al. 2008 \[[@CR108]\]Mixed4517060 (35--81)0.0379*CI* confidence interval, *DS* dietary supplement, *MVM* multivitamins/multiminerals, *SPE* summary prevalence estimate, *S95* *% CI* summary 95 % CI, *vit* vitamin

Table [3](#Tab3){ref-type="table"} shows the results of the meta-analyses of selected dietary supplements (any dietary supplements, multivitamins/multiminerals, and vitamin C) comparing sex-specific elite and non-elite athletic groups. A wide variety of sports were represented in these comparisons. With few exceptions, the SPEs demonstrated low homogeneity, with only 4 of the 12 analyses (33 %) having *Q* statistic *p* values \>0.05 and *I*^2^ values ≤50 %. There was generally little indication of publication bias, with the exception of any dietary supplement use in elite athletes. For elite athletes, the trim and fill adjusted SPE for any dietary supplement use was lower than the unadjusted values, but still higher than that of the non-elite athletes. Compared with non-elite athletes, a larger proportion of elite athletes also used multivitamins/multiminerals and vitamin C.Table 3Use of selected dietary supplement by elite and non-elite athletic statusDietary supplementStatusSexStudiesNationalityIndividual study prevalence (%)Total sample size (*n*)SPE \[% (S95 % CI)\]Homogeneity of SPETrim and fill evaluation*Q* statistic *p* value*I* ^2^ (%)Imputed studies (*n*)Adjusted SPE \[% (S95 % CI)\]Any DSEliteMenHouston 1980 \[[@CR54]\]Canadian75229769 (60--78)\<0.0194655 (45--65)Snyder et al. 1989 \[[@CR122]\]US60Kleiner et al. 1990 \[[@CR73]\]US90Berglund 2001 \[[@CR141]\]Swedish28Sundgot-Borgen et al. 2003 \[[@CR9]\]Norwegian51Ziegler et al. 2003 \[[@CR15]\]US65Nieper 2005 \[[@CR16]\]UK55Huang et al. 2006 \[[@CR198]\]Canadian71Dascombe et al. 2010 \[[@CR18]\]Australian89Kondric et al. 2010 \[[@CR124]\]Slovenian94Kim et al. 2010 \[[@CR13]\]Korean79Kim et al. 2011 \[[@CR144]\]Korean79Lazic et al. 2011 \[[@CR23]\]Serbian61WomenHouston 1980 \[[@CR54]\]Canadian50163471 (62--79)\<0.0190660 (50--69)Snyder et al. 1989 \[[@CR122]\]US86Kleiner et al. 1990 \[[@CR73]\]US100Berglund 2001 \[[@CR141]\]Swedish40Sundgot-Borgen et al. 2003 \[[@CR9]\]Norwegian54Ziegler et al. 2003 \[[@CR15]\]US76Nieper et al. 2005 \[[@CR16]\]UK75Huang et al. 2006 \[[@CR198]\]Canadian73Dascombe et al. 2010 \[[@CR18]\]Australian86Kondric et al. 2010 \[[@CR124]\]Slovenian83Kim et al. 2010 \[[@CR13]\]Korean82Kim et al. 2011 \[[@CR144]\]Korean82Lazic et al. 2011 \[[@CR23]\]Serbian61Non eliteMenNowak et al. 1988 \[[@CR78]\]US695248 (27--70)\<0.0197048 (27--70)Neiman et al. 1989 \[[@CR97]\]US30Peters and Goetzsche 1997 \[[@CR107]\]South African75Sekulic et al. 2008 \[[@CR105]\]Serbian14Knez and Peake 2010 \[[@CR101]\]Mixed58Karimian et al. 2011 \[[@CR77]\]Iranian87Dolan et al. 2011 \[[@CR102]\]US55WomenNowak et al. 1988 \[[@CR78]\]US5056142 (22--66)\<0.0194042 (22--66)Neiman et al. 1989 \[[@CR97]\]US27Peters and Goetzsche 1997 \[[@CR107]\]South African83Sekulic et al. 2008 \[[@CR105]\]Serbian24Knez and Peake 2010 \[[@CR101]\]Mixed69Karimian et al. 2011 \[[@CR77]\]Iranian11Dolan et al. 2011 \[[@CR102]\]US53MVMEliteMenHouston 1980 \[[@CR54]\]Canadian5021856 (50--63)0.910056 (50--63)Rosen et al. 1999 \[[@CR115]\]Norwegian57Ziegler et al. 2003 \[[@CR15]\]US61Kim et al. 2011 \[[@CR144]\]Korean56WomenHouston 1980 \[[@CR54]\]Canadian4219258 (31--81)\<0.0190058 (31--81)Rosen et al. 1999 \[[@CR115]\]Norwegian26Ziegler et al. 2003 \[[@CR15]\]US83Kim et al. 2011 \[[@CR144]\]Korean72Non eliteMenSandoval et al. 1989 \[[@CR70]\]US20139733 (26--41)\<0.0187033 (26--41)Nieman et al. 1989 \[[@CR97]\]US22Worme et al. 1990 \[[@CR99]\]US30Krumbach et al. 1999 \[[@CR7]\]US41Froiland et al. 2004 \[[@CR11]\]US22Kristiansen et al. 2005 \[[@CR151]\]Canadian52Kim et al. 2011 \[[@CR153]\]Korean30Dolan et al. 2011 \[[@CR102]\]US40WomenSandoval et al. 1989 \[[@CR70]\]US5073539 (30--49)\<0.0183234 (24--44)Nieman et al. 1989 \[[@CR97]\]US20Worme et al. 1990 \[[@CR99]\]US57Krumbach et al. 1999 \[[@CR7]\]US43Froiland et al. 2004 \[[@CR11]\]US26Kristiansen et al. 2005 \[[@CR151]\]Canadian63Kim et al. 2011 \[[@CR153]\]Korean30Dolan et al. 2011 \[[@CR102]\]US39Vitamin CEliteMenHouston 1980 \[[@CR54]\]Canadian384436 (26--48)0.940^aa^Rosen et al. 1999 \[[@CR115]\]Norwegian37WomenHouston 1980 \[[@CR54]\]Canadian254330 (23--40)0.670^aa^Rosen et al. 1999 \[[@CR115]\]Norwegian31Non eliteMenNeiman et al. 1989 \[[@CR97]\]US14101517 (14--20)0.2232017 (14--20)Krumbach et al. 1999 \[[@CR7]\]US20Froiland et al. 2004 \[[@CR11]\]US18Kim et al. 2011 \[[@CR153]\]Korean15WomenNeiman et al. 1989 \[[@CR97]\]US742517 (12--25)0.0367120 (13--29)Krumbach et al. 1999 \[[@CR7]\]US24Froiland et al. 2004 \[[@CR11]\]US14Kim et al. 2011 \[[@CR153]\]Korean21*CI* confidence interval, *DS* dietary supplement, *MVM* multivitamin/multimineral, *SPE* summary prevalence estimate, *S95* *% CI* summary 95 % CI^a^Not calculated with fewer than four studies

An attempt was made to examine dietary supplement use in all athletic groups combined; the results are shown in Table [4](#Tab4){ref-type="table"}. There was very little homogeneity among the studies. Of the 61 analyses, only two had a *Q* statistic *p* value \>0.05 and only one had an *I*^2^ ≤ 50 %. Despite this, the SPEs seem to indicate that the overall prevalence of dietary supplement use was high, with about 60 % of athletes using dietary supplements of any type and with vitamin/minerals, multivitamins/multiminerals, vitamin C, protein, sport drinks, and sport bars among the most commonly used. Male and female athletes had similar SPEs for most dietary supplements, with a few exceptions: compared with men, a larger proportion of women used iron and a smaller proportion used vitamin E, protein, and creatine. There was some indication of publication bias but these cases had little effect on the trim and fill adjusted SPEs.Table 4Prevalence of dietary supplement use in combined athletic groupsDietary supplementSexStudies (*n*)SPE \[% (S95 % CI)\]Homogeneity of SPETrim and fill evaluation*Q* statistic *p* value*I* ^2^Imputed studies (*n*)Adjusted SPE \[% (S95 % CI)\]Any DSM and F6160 (55--64)\<0.0197458 (54--63)M3462 (56--69)\<0.0195260 (54--67)F3158 (50--65)\<0.0192257 (49--64)Any vitamin/mineralM and F2250 (43--57)\<0.0191149(42--57)M950 (41--60)\<0.0185247 (37--57)F1452 (43--62)\<0.0182149 (40--59)MVMM and F4434 (30--40)\<0.0196233 (28--38)M2137 (31--44)\<0.0190236 (19--32)F2536 (29--44)\<0.0188235 (26--44)Vitamin AM and F106 (4--7)\<0.019116 (4--10)M64 (2--8)\<0.018815 (2--9)F53 (1--10)\<0.018625 (2--13)Vitamin B or B complexM and F2417 (12--23)\<0.0196017 (12--23)M1218 (11--28)\<0.0195018 (11--28)F1015 (9--23)\<0.0185117 (11--26)Vitamin CM and F3432 (26--39)\<0.0196133 (27--39)M1834 (25--44)\<0.0197034 (25--44)F2031 (25--38)\<0.0184841 (35--49)Vitamin DM and F107 (3--15)\<0.019607 (3--15)M510 (3--32)\<0.0194010 (3--32)F37 (2--28)\<0.0186^aa^Vitamin EM and F2413 (10--18)\<0.0194316 (12--21)M1014 (8--23)\<0.0192116 (10--25)F78 (4--15)\<0.017919 (5--17)IronM and F3017 (12--23)\<0.0195017 (12--23)M1011 (5--24)\<0.0196011 (5--24)F1823 (15--34)\<0.0194023 (15--34)CalciumM and F2512 (8--18)\<0.0194515 (11--22)M720 (7--47)\<0.0197020 (7--47)F1417 (11--25)\<0.0190321 (14--30)ZincM and F107 (5--10)\<0.018007 (5--10)M57 (4--12)0.016807 (4--12)F55 (2--13)\<0.018128 (3--17)ProteinM and F3327 (20--35)\<0.0198027 (20--35)M2036 (25--49)\<0.0178137 (25--50)F1512 (7--22)\<0.0195012 (7--22)Amino acidM and F2415 (12--20)\<0.0197015 (12--20)M1515 (9--23)\<0.0196015 (9--23)F1010 (3--23)\<0.0196010 (3--23)CreatineM and F2414 (10--20)\<0.0197014 (10--20)M1817 (11--26)\<0.0197320 (13--30)F143 (1--4)\<0.015353 (2--6)*Echinacea*M and F712 (4--29)\<0.0197012 (4--29)M311 (3--40)\<0.0187^aa^F413 (2--60)\<0.0196013 (2--60)GinsengM and F98 (5--14)\<0.019619 (5--15)M510 (6--17)\<0.0189010 (6--17)F58 (3--20)\<0.019408 (3--20)Sport drinkM and F1728 (18--24)\<0.0198028 (18--24)M1044 (24--66)\<0.0196044 (24--66)F835 (22--51)\<0.0189035 (22--51)Sport barM and F934 (22--47)\<0.0195034 (22--47)M728 (14--56)\<0.0196028 (14--28)F332 (12--62)\<0.0196032 (12--62)Ω-3-fatty acid supplementM and F614 (8--24)\<0.0194118 (10--28)M421 (12--31)\<0.0191125 (15--39)F320 (12--32)\<0.0179^aa^Energy drink^b^M and F334 (26--43)\<0.0171^aa^CaffeineM and F429 (16--46)\<0.0194124 (2--41)M220 (16--26)0.730^aa^F221 (16--24)0.1454^aa^*DS* dietary supplement, *F* females, *M* males, *MVM* multivitamin/multimineral, *SPE* summary prevalence estimate, *S95* *% CI* summary 95 % confidence interval^a^Not calculated with fewer than four studies^b^No study reported men and women separately

Discussion {#Sec13}
==========

This review illustrates the difficulty in obtaining a comprehensive description of the prevalence of dietary supplement use in athletes. Studies on this topic have used different data collection methods (e.g., dietary surveys, interviews, questionnaires), collected data on different dietary supplements, and used different reporting timeframes. The methodological quality of the studies was generally very low, with only 34 % of studies acquiring even half the available points on the Loney et al. \[[@CR28]\] checklist. Methodological quality of the studies published after the 1990s improved slightly, but average improvement was only an additional 6 % of available points (37 vs. 43 %). Using meta-analysis, an attempt was made to summarize the data by sex and sport, but few studies reported use of the same dietary supplements, and where this was the case the prevalence values in many individual studies varied widely (low homogeneity), resulting in broad S95 % CIs. Nonetheless, the tables in the present study provide a comprehensive summary of available data on the use of dietary supplements by athletes.

When comparisons were made between elite and non-elite athletes, the SPEs suggested that elite athletes tended to use dietary supplements to a greater extent than the non-elite athletes. However, prevalence ranges among studies were still wide, demonstrating low homogeneity. Further, this comparison was complicated by differences in the types of sports that might be included in the two groups. Athletes involved in different sports might be expected to use different dietary supplements, although the combined data on specific dietary supplements in specific sports was too sparse to test this hypothesis (Table [2](#Tab2){ref-type="table"}). The sex comparisons within the elite/non-elite groups might be more appropriate because the comparisons involve similar (although not identical) sports. However, the prevalence values still varied widely and the SPEs lacked homogeneity. Nonetheless, examining the individual study prevalences and the SPEs within the elite or non-elite groups suggested little difference between men and women in overall prevalence of dietary supplement use.

Like comparisons by sport and elite/non-elite status, the attempt to summarize the sex-specific prevalences of particular dietary supplements for all studies on athletes suffered from a lack of homogeneity. Nonetheless, SPEs appeared to be similar between men and women, with a few exceptions. Compared with men, a larger proportion of women appeared to use iron supplements. A much larger proportion of active women appear to be iron deficient compared with active men \[[@CR178]\], and the recommended daily allowances for iron are more than twice as high for premenopausal women (18 mg/day) than for men (8 mg/day) \[[@CR179]\]. This may lead more athletic women to supplement with iron to enhance health and/or performance. Consumption of iron supplements was associated with a lower prevalence of iron deficiency among adult women in a US national survey \[[@CR180]\]. Protein and creatine were also taken by a larger proportion of men than women, possibly because of differences in rationales for using dietary supplements. When men and women were queried separately on their reasons for using dietary supplements within the same study, men reported the development of strength and/or muscle mass as a higher priority than did women \[[@CR7], [@CR11], [@CR19]\]. Protein and creatine supplementation have both been demonstrated to increase strength and lean body mass \[[@CR181], [@CR182]\].

Table [5](#Tab5){ref-type="table"} shows summary data from the National Health Interview Surveys (NHIS) \[[@CR183]--[@CR185]\] and the National Health and Nutrition Surveys (NHANES) \[[@CR186]--[@CR189]\], both of which are nationally representative samples of the general US population. Both surveys observed a secular (temporal) trend, indicating that dietary supplement use has been increasing over time, although the most recent NHANES data suggested a leveling off in use \[[@CR188], [@CR189]\]. The increase in dietary supplement use is in consonance with data showing an eightfold increase in commercial dietary supplement sales from 1994 to 2012 \[[@CR3], [@CR4]\]. In the present review, studies were compiled by publication date in an attempt to determine whether a temporal trend was present, but no such trend could be discerned. Even the earliest studies in the literature demonstrated that a very large proportion of athletes were using dietary supplements \[[@CR54], [@CR56], [@CR83], [@CR95], [@CR139], [@CR147]\].Table 5Summary data on dietary supplement use in US national surveysSurveyStudySurvey year(s)*n*Reporting timeframePrevalence (%)Any VMMVMVitamin CMWMWMWNational Health Interview Survey (NHIS)Subar and Block 1990 \[[@CR183]\]19879160 M, 12,920 FDaily use1927152078Slesinski et al. 1995 \[[@CR184]\]19925120 M, 6885 FDaily use2027172278Millens et al. 2004 \[[@CR185]\]200034,085 M and FDaily use293924331012National Health and Nutrition Survey (NHANES)Koplan et al. 1986 \[[@CR186]\]1976--19805915 M, 6588 FUse ≥1 time/wk3040NDNDNDNDBalluz et al. 2000 \[[@CR187]\]1988--199433,905 M and FUse in last month3544NDNDNDNDRadimer et al. 2004 \[[@CR188]\]1999--20002260 M, 2602 FUse in last month465732381213Kennedy et al. 2013 \[[@CR189]\]2007--20083364 M and FUse in last month4254NDNDNDND*VM* vitamin and/or mineral, *MVM* multivitamin/multimineral, *M* males, *F* females, *ND* no data, *wk* week

Additionally, Table [5](#Tab5){ref-type="table"} includes summary data on multivitamins/multiminerals and vitamin C, mostly from the NHIS \[[@CR183]--[@CR185]\], but including one NHANES survey \[[@CR188]\]. There are some limitations in comparing these national survey data with those of the athletes. The NHIS survey asked individuals about daily use of supplements, and the NHANES asked about use in the last month. In the meta-analyses of athletes presented here (Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}) the reporting timeframe included 'current', 'usual', or 'regular' use. The athlete data were also collected over a much greater range of years than the NHIS/NHANES data, and the temporal trends differed, as noted above. Despite these limitations, a comparison of the data suggested that prevalence of use of any vitamins/minerals and multivitamins/multiminerals was somewhat higher, and that of vitamin C much higher among athletes than the general US population. Similar to the athlete data, a recent systematic review showed that the prevalence of multivitamin/multimineral and vitamin C use was higher in the military than in civilian samples \[[@CR190]\]. Military and athletic groups may be more likely to use dietary supplements because of a greater concern with health and performance \[[@CR10], [@CR35], [@CR53], [@CR149], [@CR191]--[@CR196]\]. For example, consider protein supplements. Protein supplementation in combination with resistance training augments gains in fat-free mass \[[@CR182]\]. National surveys in the USA indicate that only 1 % of the general population uses amino acid supplements \[[@CR197]\]. In contrast, the athlete data suggests a much larger prevalence of use (Table [4](#Tab4){ref-type="table"}), as does the more limited military data \[[@CR190]\].

Use of herbal supplements could be high in some athletic subgroups, especially among elite athletes. For example, use of ginseng ranged from 16 to 51 % in a study of Korean Olympic athletes \[[@CR144], [@CR153]\] and 27 % in a study of Saudi Arabian professional soccer players \[[@CR68]\]. *Echinacea* was used by 60 % of professional surfers \[[@CR123]\], 39 % of elite Australian swimmers \[[@CR58]\], and 28 and 44 % of elite male and female, respectively, figure skaters \[[@CR15]\]. Nonetheless, in most groups of athletes, 10 % or fewer used herbal supplements \[[@CR10], [@CR19], [@CR23], [@CR49], [@CR67], [@CR80], [@CR101], [@CR121], [@CR128], [@CR159], [@CR198]\]. In US national surveys, the most commonly used herbal supplements were *Echinacea*, garlic, *Ginkgo biloba*, ginseng, and Saint John's Wort, with most use prevalences well below 5 % \[[@CR185], [@CR197], [@CR199]\]. Since the studies reviewed here were conducted over a long period of time, the popularity of different supplements may have changed over time as they have in the general US population \[[@CR199], [@CR200]\].

We suspected there would be differences among studies based on nationality because of cultural and/or socioeconomic conditions. Some differences were noted in the use of ginseng, since Korean and Saudi Arabian athletes had a higher prevalence of use of this herbal supplement \[[@CR68], [@CR144], [@CR153]\] than other nationalities \[[@CR9]--[@CR12], [@CR15], [@CR19], [@CR49], [@CR58], [@CR80], [@CR131], [@CR132], [@CR141], [@CR149], [@CR152], [@CR159], [@CR198]\]. However, no other major differences were noted; there was a wide range of dietary supplement usages regardless of nationality.

Suggestions for Improving Research on Dietary Supplement Use in Athletes {#Sec14}
========================================================================

Because of the lack of homogeneity in dietary supplement use prevalences among athletes, the most appropriate way to conclude this review is to offer suggestions for improving the collection of dietary supplement data. Future studies on athletes and other groups should consider five major issues. First, the definition of dietary supplement should be clearly stated. The legal definition provided by the DSHEA of 1994 \[[@CR2]\] can serve as a standard. Second, studies should be specific about the types of dietary supplements used by study participants. Reporting in general categories like 'antioxidant', 'energy', 'herbal', 'bodybuilding', and the like may be useful for some purposes but does not provide the specificity needed for comparisons across studies or the identification of the specific dietary supplements that are being used by athletes. Third, the reporting timeframe should be specific and include several periods. The most useful reporting timeframes appear to be daily, 2--6 times/week, 1 time/week, and \<1 time/week. Fourth, the response rate (those volunteering/those solicited) should be specified and, if possible, characteristics of respondents and non-respondents described so that possible bias can be assessed. Finally, studies are needed that use the same experimental methods to compare dietary supplement use across a wide variety of sports so sport-specific differences and temporal trends can be established. Following these guidelines will assist in providing more accurate and comparable data on dietary supplement use in specific athletic populations.

Conclusions {#Sec15}
===========

When dietary supplement use was compiled by sport, elite versus non-elite athletic status, and supplement type, there was high variability in use prevalence among studies. Elite athletes appeared to use dietary supplements much more than their non-elite counterparts. For most dietary supplements, use prevalence appeared similar for men and women, with the exception of iron, creatine, protein, and vitamin E. Suggested improvements in future studies include (1) defining dietary supplements in surveys and dietary evaluations; (2) querying for very specific dietary supplements; (3) using a variety of reporting timeframes (e.g., daily, 2--6 times/week, 1 time/week and \<1 time/week); (4) reporting the sampling frame, number of individuals solicited, and number responding; (5) reporting characteristics of volunteers (and non-volunteers, if available); and (6) using similar methods on several occasions to examine possible temporal trends among athletes.
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